NextCell Pharma AB (65G)
Market Open
12 Aug, 06:08
XFRA XFRA Primary €
0. 08
-0
-4.9517%
€
9.9M Market Cap
- P/E Ratio
- Div Yield
500 Volume
0 Eps
€ 0.08
Previous Close Want to track 65G and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NextCell Pharma AB (65G) Statistics
Valuation metrics
Market Cap 9.9M
Enterprise value -
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.99
Price/Book (mrq) 0.15
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 111.39M
Float 86.02M
Shares short -
% Held by insiders 0.31%
% Held by institutions 0.07%
Average volume (10 days) 1.55K
Average volume (90 days) 4.95K
Price summary
52-Week low 0.05
52-Week high 0.17
Beta 0.65
50-Day moving average 0.1
200-Day moving average 0.08
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.16%
Operating margin -3.95%
Operational effectiveness
Return on assets -0.62%
Return on equity -0.78%
Income Statement
Revenue (ttm) 9.96M
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -0.41%
Gross profit (ttm) 1.63M
EBITDA -3.4M
Net income to common (ttm) -39.35M
Diluted EPS (ttm) -0.04
Quarterly earnings growth (yoy) 0.08%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 5.16%
Book value per share (mrq) 0.6
Cash Flow
Cash flow statement -45.23M
Levered free cash flow (LFCF) -39.35M
